The identification of prostate cancer specific genomic aberrations, ie TMPRSS2:ERG gene fusion, might improve diagnosis and affect prostate cancer treatment.     ///    Molecular diagnosis of prostate cancer: PCA3 and TMPRSS2:ERG gene fusion..     ///    The only 2 true prostate cancer specific biomarkers identified to date remain PCA3 and TMPRSS2:ERG gene fusion.. 